Health-promoting properties of Lactobacillus helveticus

Frontiers in Microbiology

Volumn 3, Issue NOV, 2012, Pages

  Taverniti, Valentina ^a   Guglielmetti, Simone ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

ACE inhibitory activity; Host bacteria cross talk; Immunomodulation; Lactobacillus helveticus; Probiotic

Indexed keywords

EID: 84874750499     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2012.00392     Document Type: Review

References (114)

1. Abubakar, A., Saito, T., Kitazawa, H., Kawai, Y., and Itoh, T. (1998). Structural analysis of new antihypertensive peptides derived from cheese whey protein by proteinase K digestion. J. Dairy Sci. 81, 3131-3138.
2. Aguilar-Nascimento, J. E., Prado, S., Zaffani, G., Salomão, A. B., Neves Jde, S., Dock-Nascimento, D. B., et al. (2006). Perioperative administration of probiotics: effects on immune response, anastomotic resistance and colonic mucosal trophism. Acta Cir. Bras. 21(Suppl. 4), 80-83.
3. Arseneault-Bréard, J., Rondeau, I., Gilbert, K., Girard, S. A., Tompkins, T. A., Godbout, R., et al. (2012). Combination of Lactobacillus helveticus R0052 and Bifidobacterium longum R0175 reduces postmyocardial infarction depression symptoms and restores intestinal permeability in a rat model. Br. J. Nutr. 107, 1793-1799.
4. Atassi, F., Brassart, D., Grob, P., Graf, F., and Servin, A. L. (2006). In vitro antibacterial activity of Lactobacillus helveticus strain KS300 against diarrhoeagenic, uropathogenic and vaginosis-associated bacteria. J. Appl. Microbiol. 101, 647-654.
5. Baba, H., Masuyama, A., and Takano, T. (2006). Short communication: effects of Lactobacillus helveticusfermented milk on the differentiation of cultured normal human epidermal keratinocytes. J. Dairy Sci. 89, 2072-2075.
6. Baba, H., Masuyama, A., Yoshimura, C., Aoyama, Y., Takano, T., and Ohki, K. (2010). Oral intake of Lactobacillus helveticus-fermented milk whey decreased transepidermal water loss and prevented the onset of sodium dodecylsulfate-induced dermatitis in mice. Biosci. Biotechnol. Biochem. 74, 18-23.
7. Baldwin, A. S. Jr. (1996). The NF-κB, and IκB proteins: new discoveries, and insights. Annu. Rev. Immunol. 14, 649-683.
8. Bandyopadhyay, J., Lee, J., Lee, J., Lee, J. I., Yu, J. R., Jee, C., et al. (2002). Calcineurin, a calcium/calmodulindependent protein phosphatase, is involved in movement, fertility, egg laying, and growth in Caenorhabditis elegans. Mol. Biol. Cell 13, 3281-3293.
9. Bao, X. Q., and Liu, G. T. (2009). Induction of overexpression of the 27and 70-kDa heat shock proteins by bicyclol attenuates concanavalin A-induced liver injury through suppression of nuclear factor-κB in mice. Mol. Pharmacol. 75, 1180-1188.
10. Beganovic, J., Frece, J., Kos, B., Leboš Pavunc, A., Habjanic, K., and Suškovic, J. (2011). Functionality of the S-layer protein from the probiotic strain Lactobacillus helveticus M92. Antonie Van Leeuwenhoek 100, 43-53.
11. Bhavsar,A. P.,Guttman,J.A.,and Finlay, B. B. (2007). Manipulation of hostcell pathways by bacterial pathogens. Nature 449, 827-834.
12. Bolognani, F., Rumney, C. J., and Rowland, I. R. (1997). Influence of carcinogen binding by lactic acidproducing bacteria on tissue distribution and in vivo mutagenicity of dietary carcinogens. Food Chem. Toxicol. 35, 535-545.
13. Borchers, A. T., Selmi, C., Meyers, F. J., Keen, C. L., and Gershwin, M. E. (2009). Probiotics and immunity. J. Gastroenterol. 44, 26-46.
14. Brandtzaeg,P.,Bjerke,K.,Kett,K.,Kvale, D., Rognum, T. O., Scott, H., et al. (1987). Production and secretion of immunoglobulins in the gastrointestinal tract. Ann. Allergy 59, 21-39.
15. Bu, G., Luo, Y., Zhang, Y., and Chen, F. (2010). Effects of fermentation by lactic acid bacteria on the antigenicity of bovine whey proteins. J. Sci. Food Agric. 90, 2015-2020.
16. Callanan, M., Kaleta, P., O'Callaghan, J., O'Sullivan, O., Jordan, K., McAuliffe, O., et al. (2008). Genome sequence of Lactobacillus helveticus, an organism distinguished by selective gene loss and insertion sequence element expansion.J.Bacteriol.190,727-735.
17. Campbell, D. J. (1987). Circulating and tissue angiotensin systems. J. Clin. Invest. 79, 1-6.
18. Canani, R. B., Costanzo, M. D., Leone, L., Pedata, M., Meli, R., and Calignano, A. (2011). Potential beneficial effects of butyrate in intestinal and extraintestinal diseases. World J. Gastroenterol. 17, 1519-1528.
19. Capcarova, M., Hascik, P., Kolesarova, A., Kacaniova, M., Mihok, M., and Pal, G. (2011). The effect of selected microbial strains on internal milieu of broiler chickens after peroral administration. Res. Vet. Sci. 91, 132-137.
20. Cavallini, D. C., Suzuki, J. Y., Abdalla, D. S., Vendramini, R. C., Pauly-Silveira, N. D., Roselino, M. N., et al. (2011). Influence of a probiotic soy product on fecal microbiota and its association with cardiovascular risk factors in an animal model. Lipids Health Dis. 10, 126.
21. Ceponis, P. J., McKay, D. M., Ching, J. C., Pereira, P., and Sherman, P. M. (2003). Enterohemorrhagic Escherichia coli O157:H7 disrupts Stat1-mediated gamma interferon signal transduction in epithelial cells. Infect. Immun. 71, 1396-1404.
22. Champagne, C. P., Tompkins, T. A., Buckley, N. D., and Green-Johnson, J. M. (2010). Effect of fermentation by pure and mixed cultures of Streptococcus thermophilus and Lactobacillus helveticus on isoflavone and B-vitamin content of a fermented soy beverage. Food Microbiol. 27, 968-972.
23. Cicero, A. F. G., Gerocarni, G., Laghi, L., and Borghi, C. (2011). Blood pressure lowering effects of lactotripeptides assumed as functional foods: a meta-analysis of current available clinical trials. J. Hum. Hypertens. 25, 425-436.
24. de Moreno de LeBlanc, A., Matar, C., Farnworth, E., and Perdigón, G. (2006). Study of cytokines involved in the prevention of a murine experimental breast cancer by kefir. Cytokine 34, 1-8.
25. de Moreno de LeBlanc, A., Matar, C., LeBlanc, N., and Perdigón, G. (2005). Effects of milk fermented by Lactobacillus helveticus R389 on a murine breast cancer model. Breast Cancer Res. 7, R477-R486.
26. Dock-Nascimento, D. B., Junqueira, K., and Aguilar-Nascimento, J. E. (2007). Rapid restoration of colonic goblet cells induced by a hydrolyzed diet containing probiotics in experimental malnutrition. Acta Cir. Bras. 22(Suppl. 1), 72-76.
27. Donkor, O. N., and Shah, N. P. (2008). Production of b-Glucosidase and hydrolysis of isoflavone phytoestrogens by Lactobacillus acidophilus, Bifidobacterium lactis, and Lactobacillus casei in soymilk. J. Food Sci. 73, M15-M20.
28. Duncan, S. H., Louis, P., and Flint, H. J. (2004). Lactate-utilizing bacteria, isolated from human feces, that produce butyrate as a major fermentation product. Appl. Environ. Microbiol. 70, 5810-5817.
29. Dziuba,J.,Minkiewicz,P.,and Nalecz,D. (1999). Biologically active peptides from plant and animal proteins. Pol. J. Food Nutr. Sci. 8, 3-16.
30. (2007) European Food Safety Authority (EFSA) Introduction of a Qualified Presumption of Safety (QPS) approach for assessment of selected microorganisms referred to EFSA. EFSA J. 587, 1-16.
31. Fagarasan, S., Kinoshita, K., Muramatsu, M., Ikuta, K., and Hinjo, T. (2001). In situ class switching and differentiation to IgA-producing cells in the gut lamina propria. Nature 413, 639-643.
32. Felton, J. S., Malfatti, M. A., Knize, M. G., Salmon, C. P., Hopmans, E. C., and Wu, R. W. (1997). Health risks of heterocyclic amines. Mutat. Res. 376, 37-41.
33. Fitzgerald, R. J., and Meisel, H. (2000). Milk protein-derived peptide inhibitors of angiotensin-Iconverting enzyme. Br. J. Nutr. 84, S33-S37.
34. (2002) Food and Agriculture Organization/ World health organization. Report of a Joint Fao/Who Expert Consultation on Guidelines for the Evaluation of Probiotics in Food,London, ON.
35. Forsythe, P., Sudo, N., Dinan, T., Taylor,V. H., and Bienenstock, J. (2010). Mood and gut feelings. Brain Behav. Immun. 24, 9-16.
36. Frece, J., Kos, B., Svetec, I. K., Zgaga, Z., Beganovic, J., Lebos,A., et al. (2009). Symbiotic effect of Lactobacillus helveticus M92 and prebiotics on the intestinal microflora and immune system of mice. J. Dairy Res. 76, 98-104.
37. Funk, C. D. (2001). Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 294, 1871-1875.
38. Gardana, C., Barbieri, A., Simonetti, P., and Guglielmetti, S. (2012). Biotransformation strategy to reduce allergens in propolis. Appl. Environ. Microbiol. 78, 4654-4658.
39. Gareau, M. G., Wine, E., Reardon, C., and Sherman, P. M. (2010). Probiotics prevent death caused by Citrobacter rodentium infection in neonatal mice. J. Infect. Dis. 201, 81-91.
40. Girard, S. A., Bah, T. M., Kaloustian, S., Lada-Moldovan, L., Rondeau, I., Tompkins, T. A., et al. (2009). Lactobacillus helveticus and Bifidobacterium longum taken in combination reduce the apoptosis propensity in the limbic system after myocardial infarction in a rat model. Br. J. Nutr. 102, 1420-1425.
41. Gobbetti, M., Ferranti, P., Smacchi, E., Goffredi, F., and Addeo, F. (2000). Production of angiotensinI-converting-enzyme-inhibitory peptides in fermented milks started by Lactobacillus delbrueckii subsp. bulgaricus SS1 and Lactococcus lactis subsp. cremoris FT4. Appl. Environ. Microbiol. 66, 3898-3904.
42. Granucci, F., Zanoni, I., Feau, S., and Ricciardi-Castagnoli, P. (2003). Dendritic cell regulation of immune responses: a new role for interleukin 2 at the intersection of innate and adaptive immunity. EMBO J. 22, 2546-2551.
43. Guglielmetti, S., De Noni, I., Caracciolo, F., Molinari, F., Parini, C., and Mora, D. (2008). Bacterial cinnamoyl esterase activity screening for the production of a novel functional food product. Appl. Environ. Microbiol. 74, 1284-1288.
44. Guglielmetti, S., Taverniti, V., Minuzzo, M.,Arioli, S., Stuknyte, M., Karp, M., et al. (2010a). Oral bacteria as potential probiotics for the pharyngeal mucosa.Appl. Environ. Microbiol. 76, 3948-3958.
45. Guglielmetti, S., Taverniti, V., Minuzzo, M., Arioli, S., Zanoni, I., Stuknyte, M., et al. (2010b). A dairy bacterium displays in vitro probiotic properties for the pharyngeal mucosa by antagonizing group A streptococci and modulating the immune response. Infect. Immun. 78, 4734-4743.
46. Hague, A., Manning, A. M., Hanlon, K. A., Huschtscha, L. I., Hart, D., and Paraskeva, C. (1993). Sodium butyrate induces apoptosis in human colonic tumor cell lines in a p53-independent pathway: implications for the possible role of dietary fiber in the prevention of large-bowel cancer. Int. J. Cancer 55, 498-505.
47. Hammes, W. P., Weiss, N., and Holzapfel, W. (1992). "The genera Lactobacillus and Carnobacterium," in The Prokaryotes, 2nd Edn, Vol. 2, eds A. Balows, H. G. Trüper, M. Dworkin, W. Harder, and K. H. Schleifer (Berlin: Springer Verlag), 1536-1594.
48. Huang, Y., Shimin, C., Nagamani, M., Anderson, K. E., Grady, J. J., and Lu, L.-J. W. (2005). Decreased circulating levels of tumor necrosis factor in postmenopausal women during consumption of soy-containing isoflavones. J. Clin. Endocrinol. Metab. 90, 3956-3962.
49. Jakala, P., Pere, E., Lehtinen, R., Turpeinen, A., Korpela, R., and Vapaatalo, H. (2009). Cardiovascular activity of milk casein-derived tripeptides and plant sterols in spontaneously hypertensive rats. J. Physiol. Pharmacol. 60, 11-20.
50. Jandu, N., Zeng, Z. J., Johnson-Henry, K. C., and Sherman, P. M. (2009). Probiotics prevent enterohaemorrhagic Escherichia coli O157:H7mediated inhibition of interferongamma-induced tyrosine phosphorylation of STAT-1. Microbiology 155, 531-540.
51. Jauhiainen, T., Niittynen, L., Orešic, M., Järvenpää, S., Hiltunen, T. P., Rönnback, M., et al. (2012). Effects of long-term intake of lactotripeptides on cardiovascular risk factors in hypertensive subjects. Eur. J. Clin. Nutr. 66, 843-849.
52. Jauhiainen, T., Rönnback, M., Vapaatalo, H., Wuolle, K., Kautiainen, H., Groop, P. H., et al. (2010). Longterm intervention with Lactobacillus helveticus fermented milk reduces augmentation index in hypertensive subjects. Eur. J. Clin. Nutr. 64, 424-431.
53. Johnson-Henry, K. C., Hagen, K. E., Gordonpour, M., Tompkins, T. A., and Sherman, P. M. (2007). Surface-layer protein extracts from Lactobacillus helveticus inhibit enterohaemorrhagic Escherichia coli O157:H7 adhesion to epithelial cells. Cell. Microbiol. 9, 356-367.
54. Joo, H. M., Kim, K. A., Myoung, K. S., Ahn, Y. T., Lee, J. H., Huh, C. S., et al. (2012). Lactobacillus helveticus HY7801 ameliorates vulvovaginal candidiasis in mice by inhibiting fungal growth and NF-κB activation. Int. Immunopharmacol. 14, 39-46.
55. Kimoto-Nira, H., Suzuki, C., Kobayashi, M., Sasaki, K., and Mizumachi, K. (2009). Inhibition of leukotriene B4 production in murine macrophages by lactic acid bacteria. Int. J. Food Microbiol. 129, 321-324.
56. Laffineur, E., Genetet, N., and Leonil, J. (1996). Immunomodulatory activity of β-casein permeate medium fermented by lactic acid bacteria. J. Dairy Sci. 79, 2112-2120.
57. Laroia, G., Cuesta, R., Brewer, G., and Schneider, R. J. (1999). Control of mRNA decay by heat shockubiquitin-proteasome pathway. Science 284, 499-502.
58. Lebeer, S., Vanderleyden, J., and De Keersmaecker, S. C. J. (2010). Host interactions of probiotic bacterial surface molecules: comparison with commensals and pathogens. Nat. Rev. Microbiol. 8, 171-184.
59. Leblanc,J.,Fliss,I.,and Matar,C. (2004). Induction of a humoral immune response following an Escherichia coli O157:H7 infection with an immunomodulatory peptidic fraction derived from Lactobacillus helveticus-fermented milk. Clin. Diagn. Lab. Immunol. 11, 1171-1181.
60. LeBlanc, J. G., Matar, C., Valdéz, J. C., LeBlanc, J., and Perdigon, G. (2002). Immunomodulating effects of peptidic fractions issued from milk fermented with Lactobacillus helveticus. J. Dairy Sci. 85, 2733-2742.
61. MacPherson, A. J., Gatto, D., Sainsbury, E., Harriman, G. R., Hengartner, H., and Zinkernagel, R. M. (2000). A primitive T cell-independent mechanism of intestinal mucosal IgA responses to commensal bacteria. Science 288, 2222-2226.
62. Maeno, M., Yamamoto, N., and Takano, T. (1996). Identification of an antihypertensive peptide from casein hydrolysate produced by a proteinase from Lactobacillus helveticus CP790. J. Dairy Sci. 79, 1316-1321.
63. Makarova, K., Slesarev, A., Wolf, Y., Sorokin, A., Mirkin, B., Koonin, E., et al. (2006). Comparative genomics of the lactic acid bacteria. Proc. Natl. Acad. Sci. U.S.A. 103, 15611-15616.
64. Maron, D. M., and Ames, B. N. (1983). Revised methods for the Salmonella mutagenicity test. Mutat. Res. 113, 173.
65. Matar, C., Nadathur, S. S., Bakalinsky, A. T., and Goulet, J. (1997). Antimutagenic effects of milk fermented by Lactobacillus helveticus L89 and a protease-deficient derivative. J. Dairy Sci. 80, 1965-1970.
66. Matar, C., Valdez, J. C., Medina, M., Rachid, M., and Perdigón, G. (2001). Immunomodulating effects of milks fermented by Lactobacillus helveticus and its non-proteolytic variant. J. Dairy Res. 68, 601-609.
67. Messaoudi, M., Lalonde, R., Violle, N., Javelot, H., Desor, D., Nejdi, A., et al. (2011). Assessment of psychotropiclike properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects. Br. J. Nutr. 105, 755-764.
68. Mitsuoka, T. (1990). Bifidobacteria, and their role in human health. J. Ind. Microbiol. 6, 263-268.
69. Morteau, O., Morham, S. G., Sellon, R., Dieleman, L. A., Langenbach, R., Smithies, O., et al. (2000). Impaired mucosal defense to acute colonic injury in mice lacking cyclooxygenase-1 or cyclooxygenase-2. J. Clin. Invest. 105, 469-478.
70. Nakamura, Y., Yamamoto, N., Sakai, K., Okubo, A., Yamazaki, S., and Takano, T. (1995). Purification and characterization of angiotensin Iconverting enzyme inhibitors from sour milk. J. Dairy Sci. 78, 777-783.
71. Neufeld, K. A., and Foster, J. A. (2009). Effects of gut microbiota on the brain: implications for psychiatry. J. Psychiatry Neurosci. 34, 230-231.
72. Ng, K.-Y., and Griffiths, M. W. (2002). Enhancement of macrophage cytokine release by cell-free fractions of fermented milk. Milchwissenschaft 57, 66-70.
73. Nowicki, B., Barrish, J. P., Korhonen, T., Hull, R. A., and Hull, S. I. (1987). Molecular cloning of the Escherichia coli O75X adhesin. Infect. Immun. 55, 3168-3173.
74. Papanicolaou, D. A., Wilder, R. L., Manolagas,S. C.,and Chrousos,G. P. (1998). The pathophysiologic roles of interleukin-6 in human disease. Ann. Intern. Med. 128, 127-137.
75. Perdigón, G., Vintini, E., Alvarez, S., Medina, M., and Medici, M. (1999). Study of the possible mechanisms involved in the mucosal immune system activation by lactic acid bacteria. J. Dairy Sci. 82, 1108-1114.
76. Pripp, A. H. (2008). Effect of peptides derived from food proteins on blood pressure: a meta-analysis of randomized controlled trials. Food Nutr. Res. 52. doi:10.3402/fnr.v52i0.1641
77. Rogers, T. R. (2002). Antifungal drug resistance: does it matter Int. J. Infect. Dis. 6, S47-S53.
78. Rossetti,L.,Carminati,D.,Zago,M.,and Giraffa, G. (2009). A qualified presumption of safety approach for the safety assessment of Grana Padano whey starters. Int. J. Food Microbiol. 130, 70-73.
79. Ruiz-Larrea, M. B., Mohan, A. R., Paganga, G., Millar, N. J., Bolwell, G. P., and Rice Evans, C. A. (1997). Antioxidant activity of phytoestrogen isoflavones. Free Radic. Res. 26, 63-70.
80. Shtrichman, R., and Samuel, C. E. (2001). The role of gamma interferon in antimicrobial immunity. Curr. Opin. Microbiol. 4, 251-259.
81. Sipola, M., Finckenberg, P., Santisteban, J., Korpela, R., Vapaatalo, H., and Nurminen, M. L. (2001). Long-term intake of milk peptides attenuates development of hypertension in spontaneously hypertensive rats. J. Physiol. Pharmacol. 52, 745-754.
82. Stidl,R.,Sontag,G.,Koller,V.,and Knasmüller, S. (2008). Binding of heterocyclic aromatic amines by lactic acid bacteria: results of a comprehensive screening trial. Mol. Nutr. Food Res. 52, 322-329.
83. Stuknyte, M., De Noni, I., Guglielmetti, S., Minuzzo, M., and Mora, D. (2011). Potential immunomodulatory activity of bovine casein hydrolysates produced after digestion with proteinases of lactic acid bacteria. Int. Dairy J. 21, 763-769.
84. Suzuki, A., Kagawa, D., Ochiai, R., Tokimitsu, I., and Saito, I. (2002). Green coffee bean extract and its metabolites have a hypotensive effect in spontaneously hypertensive rats. Hypertens. Res. 25, 99-107.
85. Takano, T. (1998). Milk derived peptides and hypertension reduction. Int. Dairy J. 8, 375-381.
86. Takeda, H., Tsuji, M., Inazu, M., Egashira, T., and Matsumiya, T. (2002). Rosmarinic acid and caffeic acid produce antidepressive-like effect in the forced swimming test in mice. Eur. J. Pharmacol. 449, 261-267.
87. Taverniti, V., and Guglielmetti, S. (2011). The immunomodulatory properties of probiotic microorganisms beyond their viability (ghost probiotics: proposal of paraprobiotic concept). Genes Nutr. 6, 261-274.
88. Taverniti, V., Minuzzo, M., Arioli, S., Junttila, I., Hämäläinen, S., Turpeinen, H., et al. (2012). In vitro functional and immunomodulatory properties of the Lactobacillus helveticus MIMLh5-Streptococcus salivarius ST3 association that are relevant to the development of a pharyngeal probiotic product. Appl. Environ. Microbiol. 78, 4209-4216.
89. Ternhag, A., Torner, A., Svensson, A., Ekdahl, K., and Giesecke, J. (2008). Shortand long-term effects of bacterial gastrointestinal infections. Emerging Infect. Dis. 14, 143-148.
90. Touaibia, M., Jean-François, J., and Doiron, J. (2011). Caffeic Acid, a versatile pharmacophore: an overview. Mini Rev. Med. Chem. 11, 695-713.
91. Trautwein, E. A., Rieckhoff, D., and Erbersdobler, H. F. (1998). Dietary inulin lowers plasma cholesterol and triacylglycerol and alters biliary bile acid profile in hamsters. J. Nutr. 128, 1937-1943.
92. Usinger, L., Ibsen, H., Linneberg, A., Azizi, M., Flambard, B., and Jensen, L. T. (2010). Human in vivo study of the renin-angiotensinaldosterone system and the sympathetic activity after 8 weeks daily intake of fermented milk. Clin. Physiol. Funct. Imaging 30, 162-168.
93. Vermeirssen, V., Van Camp, J., Decroos, K., Van Wijmelbeke, L., and Verstraete, W. (2003). The impact of fermentation and in vitro digestion on the formation of angiotensin-I-converting enzyme inhibitory activity from pea and whey protein. J. Dairy Sci. 86, 429-438.
94. Vermeirssen, V., Van Camp, J., and Verstraete, W. (2004). Bioavailability of angiotensin I converting enzyme inhibitory peptides. Br. J. Nutr. 92, 357-366.
95. Vinderola, G., Matar, C., and Perdigón, G. (2007a). Milk fermentation products of L. helveticus R389 activate calcineurin as a signal to promote gut mucosal immunity. BMC Immunol. 8, 19. doi:10.1186/14712172-8-19
96. Vinderola, G., Matar, C., and Perdigón, G. (2007b). Milk fermented by Lactobacillus helveticus R389 and its non-bacterial fraction confer enhanced protection against Salmonella enteritidis serovar Typhimurium infection in mice. Immunobiology 212, 107-118.
97. Vinderola, G., Matar, C., Palacios, J., and Perdigón, G. (2007c). Mucosal immunomodulation by the nonbacterial fraction of milk fermented by Lactobacillus helveticus R389. Int. J. Food Microbiol. 115, 180-186.
98. Vitali, B., Ndagijimana, M., Maccaferri, S., Biagi, E., Guerzoni, M. E., and Brigidi, P. (2012). An in vitro evaluation of the effect of probiotics and prebiotics on the metabolic profile of human microbiota. Anaerobe 18, 386-391.
99. Wagar, L. E., Champagne, C. P., Buckley, N. D., Raymond, Y., and Green-Johnson, J. M. (2009). Immunomodulatory properties of fermented soy and dairy milks prepared with lactic acid bacteria. J. Food Sci. 74, M423-M430.
100. Wann, B. P., Boucher, M., Kaloustian, S., Nim, S., Godbout, R., and Rousseau, G. (2006). Apoptosis detected in the amygdala following myocardial infarction in the rat. Biol. Psychiatry 59, 430-433.
101. Weng, C. J., and Yen, G. C. (2012). Chemopreventive effects of dietary phytochemicals against cancer invasion and metastasis: phenolic acids, monophenol, polyphenol, and their derivatives. Cancer Treat. Rev.38, 76-87.
102. Williams, C. S., Mann, M., and DuBois, R. N. (1999). The role of cyclooxygenases in inflammation, cancer, and development. Oncogene 18, 7908-7916.
103. Wine, E., Gareau, M. G., Johnson-Henry, K., and Sherman, P. M. (2009). Strain-specific probiotic (Lactobacillus helveticus) inhibition of Campylobacter jejuni invasion of human intestinal epithelial cells. FEMS Microbiol. Lett. 300, 146-152.
104. Wise, R., Hart, T., Cars, O., Streulens, M., Helmuth, R., Huovinen, P., et al. (1998). Antimicrobial resistance. Is a major threat to public health. BMJ 317, 609-610.
105. (2004) World Health Organization (WHO). The World Health Report 2004 Changing History. Available at: http://www.who.int/whr/2004/en/ [accessed September 1, 2012]
106. Xing, Z., Gauldie, J., Cox, G., Baumann, H., Jordana, M., Lei, X. F., et al. (1998). IL-6 is an anti-inflammatory cytokine required for controlling local or systemic acute inflammatory responses. J. Clin. Invest. 101, 311-320.
107. Xu, J. Y., Qin, L. Q., Wang, P. Y., Li, W., and Chang, C. (2008). Effect of milk tripeptides on blood pressure: a meta-analysis of randomized controlled trials. Nutrition 24, 933-940.
108. Yamamoto, N., Akino, A., and Takano, T. (1993). Purification and specificity of a cell-wall-associated proteinase from Lactobacillus helveticus CP790. J. Biochem. 114, 740-745.
109. Yamamoto,N.,Akino,A.,and Takano,T. (1994a). Antihypertensive effect of the peptides derived from casein by an extracellular proteinase from Lactobacillus helveticus CP790. J. Dairy Sci. 77, 917-922.
110. Yamamoto,N.,Akino,A.,and Takano,T. (1994b). Antiohypertensive effects of different kinds of fermented milk in spontaneously hypertensive rats. Biosci. Biotechnol. Biochem. 58, 776-778.
111. Yamamoto, N., Maeno, M., and Takano, T. (1999). Purification and characterization of an antihypertensive peptide from a yogurt-like product fermented by Lactobacillus helveticus CPN4. J. Dairy Sci. 82, 1388-1393.
112. Yamamoto,Y., and Gaynor, R. B. (2001). Therapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancer. J. Clin. Invest. 107; 135-142.
113. Yamamura,S.,Morishima,H.,Kumanogo, T., Suganuma, N., Matsumoto, H., Adachi, H., et al. (2009). The effect of Lactobacillus helveticus fermented milk on sleep and health perception in elderly subjects. Eur. J. Clin. Nutr. 63, 100-105.
114. Zubenko, G. S., and Nixon, R. A. (1984). Mood-elevating effect of captopril in depressed patients. Am. J. Psychiatry 141, 110-111.